Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Nordic Biotech K/S
K/S
Active
CVR 26290724
Strandvejen 125, 2900
Hellerup
Other financial service activities, except insurance and pension funding n.e.c.
·
NACE 6499
Est. 2001 · 24 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Other financial service activities, except insurance and pension funding n.e.c.
/
Nordic Biotech K/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
0M
-1M
-1M
2020: not reported
2020
2021: not reported
2021
2022: not reported
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
EBITDA
DKK millions
0M
-14M
-28M
-42M
-56M
2020: -1M
-1M
2020
2021: -6M (-500% vs 2020)
-6M
-500%
2021
2022: -45M (-650% vs 2021)
-45M
-650%
2022
2023: 0M (+100% vs 2022)
0M
2023
2024: 0M
0M
2024
Income statement
DKK thousands
Item
2024
2023
2022
2021
2020
Gross profit
-157
-133
—
—
—
Staff expenses
-0
-0
-0
-0
-0
EBITDA
-157
-133
-44.568
-6.381
-1.354
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
-157
-133
-44.568
-6.381
-1.354
Net financials
101.615
1.387
-44.454
-6.268
-1.262
Profit before tax
101.458
1.254
-44.572
-6.387
-1.360
Tax
-0
-0
-0
-0
-0
Net profit
101.458
1.254
-44.572
-6.387
-1.360
Balance sheet
DKK thousands
Item
2024
2023
2022
2021
2020
Total assets
127.129
32.326
34.208
78.784
85.170
Equity
127.032
32.232
34.150
78.722
85.109
Long-term debt
0
0
0
0
0
Short-term debt
97
94
58
63
61
Total debt
97
94
58
63
61
Financial ratios
5-year trend
EBITDA margin (of gross profit)
<−999 %
This company
2020
2024
Equity ratio
99,9 %
This company
38,2 %
Market median
This company
Market median
162% above market
2020
2024
Return on equity
79,9 %
This company
18,4 %
Market median
This company
Market median
334% above market
2020
2024
Net profit margin (of gross profit)
>999 %
This company
2020
2024
Asset turnover (of gross profit)
-0,00×
This company
2020
2024
Debt / equity
0,00×
This company
0,62×
Market median
This company
Market median
100% below market
2020
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
View
PDF
More on Nordic Biotech K/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
